Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
RET inhibitor shrank tumors in more than half of people with non-small-cell lung cancer and aggressive thyroid cancer.
Together we will speak with one voice to our elected officials. You are the change for lung cancer.
The test was able to identify many cancers, and their location, at early stages.
New immunotherapy option approved for uncommon, aggressive type of lung cancer.
A Phase II trial reached its primary endpoint of overall response in just over a third of participants.
Singer-songwriter John Prine’s songs have embraced pain with kindness and a wicked and whimsical sense of humor.
The immunotherapy drug shows the most benefit for newly treated people with tumors that test positive for the PD-L1 biomarker.
HIV-positive individuals are also diagnosed with cancer at later stages than those without the virus.
Keytruda and Imfinzi showed response rates and safety profiles similar to those seen in HIV-negative people.
AMG 510 shrank tumors in half of lung cancer patients with a mutation thought to be “undruggable.”
Researchers believe specially designed cancer care programs could prevent Black patients from being lost to care.
Special section on adults ages 20 to 49 shows higher cancer incidence and mortality for women than men.
Researchers analyzed treatment patterns among people diagnosed with four major forms of metastatic cancer.
Research shows people with cancer who quit smoking respond better to treatment and are more likely to survive cancer.
A new systematic review and meta-analysis indicates that hepatitis C is most notably also associated with B-cell non–Hodgkin lymphoma.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.